Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 50, Issue 11, 2004, Pages 3580-3590

  Anolik, Jennifer H ^a   Barnard, Jennifer ^a   Cappione, Amedeo ^a   Pugh Bernard, Aimee E ^b   Felgar, Raymond E ^a   Looney, R John ^a   Sanz, Iñaki ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; CD20 ANTIBODY; CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN D; RITUXIMAB;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; LYMPHOCYTE DEPLETION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; B-LYMPHOCYTES; FEMALE; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LEUKAPHERESIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 8444223507     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20592     Document Type: Article

References (51)

1. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999;189:1639-48.
2. Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994;180:1295-306.
3. Chan OT, Madaio MP, Shlomchik MJ. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999;169:107-21.
4. Harris D, Haynes L, Sayles P, Duso DK, Eaton SM, Lepak NM, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000;1:475-81.
5. Wakeland E, Liu K, Graham R, Behrens T. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001;15:397-408.
6. Mohan C. Murine lupus genetics: lessons learned. Curr Opin Rheumatol 2001;13:352-60.
7. Qian Y, Wang H, Clarke S. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J Immunol 2004;172:625-35.
8. Folzenlogen D, Hofer MF, Leung DY, Freed JH, Newell MK. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 1997;83:199-204.
9. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063-73.
10. Avery D, Kalled S, Ellyard J, Ambrose C, Bixler SA, Thien M, et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 2003;112:286-97.
11. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 2001;166:6-10.
12. Odendahl M, Jacobi A, Hansen A, Feist T, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000;165:5970-9.
13. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001;167:2361-9.
14. Cappione A, Pugh-Bernard A, Anolik JH, Sanz I. Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol 2004;172:4298-307.
15. Anolik JH, Campbell D, Ritchlin C, Holyst M, Rosenfeld S, Varnis C, et al. B lymphocyte depletion as a novel treatment for systemic lupus erythematosus (SLE): phase I/II trial of rituximab (Rituxan®) in SLE [abstract]. Arthritis Rheum 2001;44 Suppl 9:S387.
16. Leandro M, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA. An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 2002;46:2673-7.
17. Edwards J, Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology 2001;40:205-11.
18. Looney RJ, Anolik JH, Campbell D, Felger RE, Young F, Arend LJ, et al. B cell depletion as a novel treatment for systemic lupus erythematosus. Arthritis Rheum 2004;50:2580-9.
19. Anolik J, Sanz I, Looney RJ. B cell depletion therapy in systemic lupus erythematosus. Curr Rheumatol Rep 2003;5:350-6.
20. Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt J, et al. The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum 2003;48:455-9.
21. Tan E, Cohen A, Fries J, Masi A, McShane D, Rothfield N. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
23. Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, Insel RA, et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001;108:1061-70.
24. Maurer D, Fischer GF, Fae I, Majdic O, Stuhlmeier K, Von Jeney N, et al. IgM and IgG but not cytokine secretion is restricted to the CD274+ B lymphocyte subset. J Immunol 1992;148:3700-5.
25. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994;180:329-39.
26. Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001;167:3610-8.
27. Harada Y, Kawano M, Huang N, Mahmoud MS, Lisukov IA, Mihara K, et al. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996;92:184-91.
28. Anolik JH, Cappione A, Looney RJ, Sanz I, Young F. Abnormalities in B lymphocyte signaling in human SLE. Arthritis Rheum 2002;46:S415.
29. Huang W, Sinha J, Newman J, Reddy B, Budnai L, Furie R, et al. The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus. Arthritis Rheum 2002;46:1554-62.
30. Cerny A, Starobinski M, Hugin AW, Sutter S, Zinkernagel RM, Isui S. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NSW x BXSB)F1 hybrid mice. J Immunol 1987;138:4222-8.
31. Connolly K, Roubinian J, Wofsy D. Development of murine lupus in CD4-depleted NZB/NZW mice: sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity. J Immunol 1992;149:3083-8.
32. Grillo-Lopez A, White C, Varns C, Shen D, Wei A, McClure A, et al. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 1999;26:66-73.
33. Schroder C, Azimzadeh A, Wu G, Price J, Atkinson J, Pierson R. Anti-CD20 treatment depletes B cells in blood and lymphatic tissue of cynomolgus monkeys. Transpl Immunol 2003;12:19-28.
34. Johnson P, Glennie M. The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol 2003;30:3-8.
35. Silverman G, Weisman S. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 2003;48:1484-92.
36. Anolik JH, Looney RJ, Bottaro A, Sanz I, Young F. Down-regulation of CD20 on B cells upon CD40 activation. Eur J Immunol 2003;33:2398-409.
37. Cappione A, Anolik J, Barnard J, Pugh-Bernard A, Dutcher P, Sanz I. Defective germinal center censoring of autoreactive B cells in human SLE. Arthritis Rheum 2003;48:S193.
38. Mamula MJ, Fatenejad S, Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 1994;152:1453-61.
39. Linton PJ, Harbertson J, Bradley LM. A critical role for B cells in the development of memory CD4 cells. J Immunol 2000;165:5558-65.
40. Skok J, Poudrier J, Gray D. Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development. J Immunol 1999;163:4284-91.
41. Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell deficient mice results in T helper cell type 1 deviation. J Exp Med 2000;192:475-82.
42. Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI, et al. Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 1995;59:279-368.
43. Meffre E, Schaefer A, Wardemann H, Wilson P, Davis E, Nussenzweig M. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J Exp Med 2004;199:145-50.
44. Wardemann H, Yurasov S, Schaefer A, Young J, Meffre E, Nussenzweig M. Predominant autoantibody production by early human B cell precursors. Science 2003;301:1374-7.
45. Ueda Y, Yang K, Foster S, Kondo M, Kelsoe G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med 2004;199:47-58.
46. Bernasconi N, Traggiai E, Lanzavecchia A. Maintenance of serologic memory by polyclonal activation of human memory B cells. Science 2002;298:2199-202.
47. Manz R, Arce S, Cassese G, Hauser A, Hiepe F, Radbruch A. Humoral immunity and long-lived plasma cells. Curr Opin Immunol 2002;14:517-21.
48. Slifka M, Antia R, Whitmire J, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998;8:363-72.
49. Cassese G, Lindenau S, de Boer B, Arce S, Hauser A, Riemekasten G, et al. Inflamed kidneys of NZBAV mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001;31:2726-32.
50. Hoyer B, Moser K, Hauser A, Peddinghaus A, Voight C, Eilat D, et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004;199:1577-84.
51. Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004;197:179-91.